Bio-K will expand Kerry’s current portfolio of probiotics.
Kerry (Dublin, Ireland) acquired the Canadian company Bio-K Plus International (Armand-Frappier Laval, Quebec, Canada), a probiotic company with a range of clinically supported probiotic beverage and supplement applications. Bio-K will expand Kerry’s current portfolio of probiotics.
“We are committed to creating a world of sustainable nutrition and this acquisition will support our ambition to reach over two billion people with sustainable nutrition solutions by 2030,” said Neil Cracknell, president of Kerry Applied Health & Nutrition, in a press release. “Research has shown that consumers are increasingly looking for nutritional benefits when purchasing food and drink and that products which contain probiotics that improve gut health are specifically in demand. Bio-K Plus further expands our portfolio of probiotics with the addition of three science-backed strains as we continue to help enhance the health & wellness of consumers across the globe by having a strong complement of published clinical trials confirming efficacy.”
Kerry has been expanding its position in functional ingredients for several years, with the acquisition of immune-health ingredient Wellmune in 2015, followed by the leading probiotic GanedenBC30 in 2017.